We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

56 hedge funds and large institutions have $146M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 2

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

180% more funds holding

Funds holding: 20 → 56 (+36)

104% more capital invested

Capital invested by funds: $71.9M → $146M (+$74.6M)

Holders
56
Holders Change
+36
Holders Change %
+180%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
5
Reduced
1
Closed
2
Calls
$100K
Puts
–
Net Calls
+$100K
Net Calls Change
+$100K

Top Buyers

Rank Fund Capital Flow
1
MI
MMCAP International
Cayman Islands
+$9.93M
2
PC
Periscope Capital
Ontario, Canada
+$6.97M
3
LA
Linden Advisors
New York
+$6.95M
4
SC
Sculptor Capital
New York
+$4.97M
5
CSS
Cubist Systematic Strategies
Connecticut
+$4.24M

Top Sellers

Rank Fund Capital Flow
1
NAM
Nexpoint Asset Management
Texas
-$2.57M
2
HCM
Highbridge Capital Management
New York
-$2.25M
3
CS
Clear Street
New York
-$19K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$15.7M – – –
SC
2
Sculptor Capital
New York
$10M +$4.97M +500,000 +100%
MI
3
MMCAP International
Cayman Islands
$10M +$9.93M +1,000,000 New
HCM
4
Highbridge Capital Management
New York
$8.97M -$2.25M -226,413 -20%
PC
5
Periscope Capital
Ontario, Canada
$7.02M +$6.97M +702,100 New
LA
6
Linden Advisors
New York
$7M +$6.95M +700,000 New
Citadel Advisors
7
Citadel Advisors
Florida
$6M – – –
BCM
8
Beryl Capital Management
California
$5.65M – – –
Marshall Wace
9
Marshall Wace
United Kingdom
$5.25M +$4.12M +414,373 +373%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$5.1M +$4.07M +410,051 +410%
PAMP
11
Polar Asset Management Partners
Ontario, Canada
$5M – – –
CSS
12
Cubist Systematic Strategies
Connecticut
$4.27M +$4.24M +427,242 New
WRBC
13
W.R. Berkley Corp
Connecticut
$4.06M – – –
CF
14
Cantor Fitzgerald
New York
$4M +$3.97M +400,000 New
RCM
15
Radcliffe Capital Management
Pennsylvania
$3M – – –
SCM
16
Shaolin Capital Management
Florida
$2.97M +$2.95M +297,174 New
FTCM
17
Fir Tree Capital Management
New York
$2.97M – – –
AA
18
AQR Arbitrage
Connecticut
$2.86M +$2.84M +286,090 New
AC
19
Aristeia Capital
Connecticut
$2.5M +$2.48M +250,000 New
TCM
20
Tenor Capital Management
New York
$2.5M +$2.48M +250,000 New
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
$2.5M – – –
SCC
22
Spring Creek Capital
Kansas
$2.5M +$2.48M +250,000 New
WAM
23
Weiss Asset Management
Massachusetts
$2.42M – – –
Goldman Sachs
24
Goldman Sachs
New York
$2.02M +$2.01M +202,134 New
PMAM
25
Picton Mahoney Asset Management
Ontario, Canada
$2M +$1.99M +200,000 New
1
2 3

IQMD Hedge Fund Activity: Q1 2022 in Review

56 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q1 2022, worth a combined $146M — up 104% from $71.9M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IQMD positions and 2 closed out — a net gain of 36 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $9.93M. The largest seller was Nexpoint Asset Management, exiting entirely with an estimated $2.57M sold.

  • 56 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q1 2022, up from 20 in Q4 2021.
  • Funds reported $146M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q1 2022, up 104% quarter-over-quarter.
  • 38 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q1 2022 and 2 closed out, a net change of +36 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q1 2022 was MMCAP International, an estimated $9.93M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q1 2022 was Nexpoint Asset Management, an estimated $2.57M sold.

Based on aggregated 13F filings for Q1 2022.